Clinical Trial

A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

Name: A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors — clinical trial record (NCT06752447)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A non-randomized, open-ended, phase I dose-escalation and dose-expansion study was designed to evaluate the safety, tolerability, antitumor efficacy, PK and immunogenic characteristics of LNF2007 in patients with advanced solid tumors

Trial Details

NCT Number	NCT06752447
Lead Sponsor	Shandong New Time Pharmaceutical Co., LTD
Conditions	Advanced Solid Tumors (Phase 1)
Enrollment	94 participants
Start Date	2025-01-20
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2024-12-30